PRAME

GI:46249373

preferentially expressed antigen in melanoma

     1  merrrlwgsi qsryismsvw tsprrlvela gqsllkdeal aiaalellpr  50    
    51  elfpplfmaa fdgrhsqtlk amvqawpftc lplgvlmkgq hlhletfkav  100   
   101  ldgldvllaq evrprrwklq vldlrknshq dfwtvwsgnr aslysfpepe  150   
   151  aaqpmtkkrk vdglsteaeq pfipvevlvd lflkegacde lfsyliekvk  200   
   201  rkknvlrlcc kklkifampm qdikmilkmv qldsiedlev tctwklptla  250   
   251  kfspylgqmi nlrrlllshi hassyispek eeqyiaqfts qflslqclqa  300   
   301  lyvdslfflr grldqllrhv mnpletlsit ncrlsegdvm hlsqspsvsq  350   
   351  lsvlslsgvm ltdvspeplq allerasatl qdlvfdecgi tddqllallp  400   
   401  slshcsqltt lsfygnsisi salqsllqhl iglsnlthvl ypvplesyed  450   
   451  ihgtlhlerl aylharlrel lcelgrpsmv wlsanpcphc gdrtfydpep  500   
   501  ilcpcfmpn